These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2285302)

  • 41. Laboratory detection methods for methicillin resistance in coagulase negative Staphylococcus isolated from ophthalmic infections.
    Oliveira AD; d'Azevedo PA; de Sousa LB; Viana-Niero C; Francisco W; Lottenberg C; Martino MD; Höfling-Lima AL
    Arq Bras Oftalmol; 2007; 70(4):667-75. PubMed ID: 17906764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci and Acinetobacter species.
    Frank U; Daschner FD
    Infection; 1989; 17(4):272-4. PubMed ID: 2767773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
    Ishii Y; Ueda C; Kouyama Y; Tateda K; Yamaguchi K
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):443-8. PubMed ID: 21396543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH; Houck HJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative in vitro activity ampicillin, cefoperazone, their combinations with sulbactam, as well as that of other antibiotics against aerobic gram-negative microorganisms].
    Sidorenko SV; Rezvan SP; Speranskaia ON; Krotova LA; Tikhonova AS; Strachunskiĭ LS; Navashin SM; Kuleshov SE; Budanov SV; Ansolis LE
    Antibiot Khimioter; 1994 Nov; 39(11):10-20. PubMed ID: 7733770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
    Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
    Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
    Urban C; Go E; Mariano N; Berger BJ; Avraham I; Rubin D; Rahal JJ
    J Infect Dis; 1993 Feb; 167(2):448-51. PubMed ID: 8421178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of cefoperazone/sulbactam and other antimicrobials against anaerobic bacteria.
    D'Amato RF; Hochstein L; Frankel H
    Diagn Microbiol Infect Dis; 1990; 13(1):51-5. PubMed ID: 2331850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Oct; 25(10):1920-5. PubMed ID: 3117843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [In vitro antibiotic susceptibility of staphylococci].
    Baykal M; Akalin HE
    Mikrobiyol Bul; 1989 Apr; 23(2):157-62. PubMed ID: 2626105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
    Van der Auwera P; Van Laethem Y; Klastersky J
    J Antimicrob Chemother; 1987 Aug; 20(2):239-49. PubMed ID: 3478329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
    Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
    Jpn J Antibiot; 1991 Feb; 44(2):130-9. PubMed ID: 2041154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species.
    Goldstein EJ; Citron DM
    J Antimicrob Chemother; 1996 Oct; 38(4):733-7. PubMed ID: 8937969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa].
    Niida M; Yoshida T; Kohmoto A; Ogawa M; Hashimoto H; Deguchi K
    Jpn J Antibiot; 1994 Jan; 47(1):1-10. PubMed ID: 8114267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.
    Zinner SH; Gilbert D; Dudley MN
    Antimicrob Agents Chemother; 1998 Jan; 42(1):72-7. PubMed ID: 9449263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
    Fuchs PC; Stickel S; Anderson PH; Barry AL; Shilling S
    Antimicrob Agents Chemother; 1991 Jan; 35(1):182-4. PubMed ID: 2014975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.